The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity
The Journal of Immunology · 02.11.2026 · 215 (11)
DOI: 10.1093/jimmun/vkag288 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 04.11.2026. Verfasst von Victoria Volfson-Sedletsky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Arthritis and Autoimmune Diseases Center, Rheumatology Section, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, T-Lymphocyte Subsets, Th1 Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Scleroderma Foundation, NIAMS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
T cells in patients with chronic autoimmunity show features of dysfunction. However, the functionally defined T cell subsets that are affected by these changes remain poorly characterized. Here, we sought to reveal aberrations in the composition, phenotype, and function of canonical T cell subsets in the blood of systemic sclerosis (SSc) patients compared with healthy subjects and systemic lupus erythematosus (SLE) patients. Therefore, we developed a novel multidimensional flow-cytometry panel to simultaneously detect lineage-defining transcription factors, co-inhibitory receptors and other functional markers to characterize T cell subsets without in vitro restimulation. We compared T cell landscapes in SSc and SLE patients, and healthy subjects, using opt-SNE (optimized t-distributed stochastic neighbor embedding) and PhenoGraph algorithms. The data show altered distribution and aberrant functional states of transcription factor–defined T cell subsets in patients with autoimmunity, with shared and unique features between diseases and their subtypes. Strikingly, SSc and SLE patients showed deficiencies in subsets of CD8+ and CD4−CD8− T cells that expressed T-bet, which is critical for IFN-γ–dependent type 1 immunity. Moreover, TIGIT+Foxp3+ regulatory T cells, which suppress T helper 1 responses, were increased in diffuse cutaneous SSc and SLE patients. Functionally, T cells from SSc patients produced less IFN-γ, a cytokine that suppresses profibrotic gene expression in fibroblasts, as we demonstrate by transcriptomic analysis. Our study supports a model in which IFN-γ opposes canonical fibrotic gene programs in fibroblasts, and deficiencies in the IFN-γ–producing T cell compartment in SSc patients therefore may contribute to chronic fibrosis development. Aberrant T cell subsets in SSc and SLE represent targets for corrective immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Arthritis and Autoimmune Diseases Center, Rheumatology Section, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA, United States.
- Department of Virology, Immunology and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA, United States.
- Center for Systems Immunology, Benaroya Research Institute, Seattle, WA, United States.
- Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA, United States.
- Renal Section, Department of Medicine, Boston Medical Center, Boston, MA, United States.
- Renal Section, Department of Medicine, VA Boston Healthcare System, Boston, MA, United States.
ORCID-Profile: Hannah A DeBerg, Mitch L Fahning, Ian R Rifkin, Andreea M Bujor, Daniel J Campbell, Peter A Morawski, Anna C Belkina, Hans Dooms
Förderung
- National Scleroderma Foundation
- NIAMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- NHLBI NIH HHS
- NIAID NIH HHS
- NIH HHS
- New Investigator research
- Walter and Marie Coyle research
Zitieren
APA
Volfson-Sedletsky, V., DeBerg, H. A., Fahning, M. L., Rifkin, I. R., Bujor, A. M., Campbell, D. J., Morawski, P. A., Belkina, A. C., & Dooms, H. (2026). The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag288
Vancouver
Volfson-Sedletsky V, DeBerg HA, Fahning ML, Rifkin IR, Bujor AM, Campbell DJ, et al. The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag288
BibTeX
@article{VolfsonSedletsky2026,
author = {Volfson-Sedletsky, Victoria and DeBerg, Hannah A and Fahning, Mitch L and Rifkin, Ian R and Bujor, Andreea M and Campbell, Daniel J and Morawski, Peter A and Belkina, Anna C and Dooms, Hans},
title = {The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {11},
doi = {10.1093/jimmun/vkag288}
}
EUVIMED